Serum infliximab concentrations and disease activity: a descriptive study of patients with psoriasis

被引：4
作者：
Dannepond, C. [1 ]
Ternant, D. [2 ]
Maruani, A. [1 ,3 ]
Machet, L. [1 ,3 ]
Paintaud, G. [2 ]
Samimi, M. [1 ,4 ]
机构：
[1] Univ Tours, Dept Dermatol, Hosp Tours, Tours, France
[2] Hosp Tours, Lab Pharmacol Toxicol, CNRS, GICC UMR 7292, Tours, France
[3] INSERM, Imagerie & Cerveau UMR U930, Tours, France
[4] Univ Tours, INRA ISP, UMR 1282, Tours, France
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2016年 / 174卷 / 01期
关键词：
SEVERE PLAQUE PSORIASIS; MODERATE; MULTICENTER; ANTIBODIES; THERAPY;
D O I：
10.1111/bjd.13831
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
[No abstract available]
引用
收藏
页码：198 / 200
页数：3
相关论文
共 15 条
  • [1] [Anonymous], J CROHNS COLITIS
  • [2] Serum Infliximab Concentrations in Psoriatic Patients Treated with Infliximab: A Systematic Review
    Dannepond, Carole
    Maruani, Annabel
    Machet, Laurent
    Ternant, David
    Paintaud, Gilles
    Samimi, Mahtab
    [J]. ACTA DERMATO-VENEREOLOGICA, 2015, 95 (04) : 401 - 406
  • [3] The efficacy and safety of infliximab in patients with plaque psoriasis who had an inadequate response to etanercept: Results of a prospective, multicenter, open-label study
    Gottlieb, Alice B.
    Kalb, Robert E.
    Blauvelt, Andrew
    Heffernan, Michael P.
    Sofen, Howard L.
    Ferris, Laura Korb
    Kerdel, Francisco A.
    Calabro, Stephen
    Wang, Jim
    Kerkmann, Urs
    Chevrier, Marc
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2012, 67 (04) : 642 - 650
  • [4] Kopylov U, 2014, ANN GASTROENTEROL, V27, P304
  • [5] Long-term durability and dose escalation patterns in infliximab therapy for psoriasis
    Luber, Adam J.
    Tsui, Cindy L.
    Heinecke, Gillian M.
    Lebwohl, Mark G.
    Levitt, Jacob O.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2014, 70 (03) : 525 - 532
  • [6] A randomized comparison of continuous vs. intermittent infliximab maintenance regimens over 1 year in the treatment of moderate-to-severe plaque psoriasis
    Menter, Alan
    Feldman, Steven R.
    Weinstein, Gerald D.
    Papp, Kim
    Evans, Robert
    Guzzo, Cynthia
    Li, Shu
    Dooley, Lisa T.
    Arnold, Cynthia
    Gottlieb, Alice B.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2007, 56 (01) : 31 - 44
  • [7] Lack of Anti-drug Antibodies in Patients with Psoriasis Well-controlled on Long-term Treatment with Tumour Necrosis Factor Inhibitors
    Meyer, Martin W.
    Zachariae, Claus
    Bendtzen, Klaus
    Skov, Lone
    [J]. ACTA DERMATO-VENEREOLOGICA, 2012, 92 (04) : 362 - 364
  • [8] Definition of treatment goals for moderate to severe psoriasis: a European consensus
    Mrowietz, U.
    Kragballe, K.
    Reich, K.
    Spuls, P.
    Griffiths, C. E. M.
    Nast, A.
    Franke, J.
    Antoniou, C.
    Arenberger, P.
    Balieva, F.
    Bylaite, M.
    Correia, O.
    Dauden, E.
    Gisondi, P.
    Iversen, L.
    Kemeny, L.
    Lahfa, M.
    Nijsten, T.
    Rantanen, T.
    Reich, A.
    Rosenbach, T.
    Segaert, S.
    Smith, C.
    Talme, T.
    Volc-Platzer, B.
    Yawalkar, N.
    [J]. ARCHIVES OF DERMATOLOGICAL RESEARCH, 2011, 303 (01) : 1 - 10
  • [9] Infliximab concentration monitoring improves the control of disease activity in rheumatoid arthritis
    Mulleman, Denis
    Meric, Jean-Camille
    Paintaud, Gilles
    Ducourau, Emilie
    Magdelaine-Beuzelin, Charlotte
    Valat, Jean-Pierre
    Goupille, Philippe
    [J]. ARTHRITIS RESEARCH & THERAPY, 2009, 11 (06)
  • [10] Trough Infliximab Concentrations Predict Efficacy and Sustained Control of Disease Activity in Rheumatoid Arthritis
    Mulleman, Denis
    Lin, Delphine Chu Miow
    Ducourau, Emilie
    Emond, Patrick
    Ternant, David
    Magdelaine-Beuzelin, Charlotte
    Valat, Jean-Pierre
    Paintaud, Gilles
    Goupille, Philippe
    [J]. THERAPEUTIC DRUG MONITORING, 2010, 32 (02) : 232 - 236
12